Advanced search
Publication Cover
Ophthalmic Epidemiology Volume 25, 2018 - Issue 4
Submit an article Journal homepage
291
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Regression Discontinuity and Randomized Controlled Trial Estimates: An Application to The Mycotic Ulcer Treatment Trials

Catherine E. OldenburgFrancis I. Proctor Foundation, University of California, San Francisco, USACorrespondence[email protected]
View further author information
,
N. Venkatesh PrajnaAravind Eye Care System, Madurai, IndiaView further author information
,
Tiruvengada KrishnanAravind Eye Care System, Pondicherry, IndiaView further author information
,
Revathi RajaramanAravind Eye Care System, Coimbatore, IndiaView further author information
,
Muthiah SrinivasanAravind Eye Care System, Madurai, IndiaView further author information
,
Kathryn J. RayFrancis I. Proctor Foundation, University of California, San Francisco, USAView further author information
,
Kieran S. O’BrienFrancis I. Proctor Foundation, University of California, San Francisco, USAView further author information
,
M. Maria GlymourDepartment of Epidemiology and Biostatistics, University of California, San Francisco, USAView further author information
,
Travis C. PorcoFrancis I. Proctor Foundation, University of California, San Francisco, USA;Department of Epidemiology and Biostatistics, University of California, San Francisco, USA;Department of Ophthalmology, University of California, San Francisco, USAView further author information
,
Nisha R. AcharyaFrancis I. Proctor Foundation, University of California, San Francisco, USA;Department of Epidemiology and Biostatistics, University of California, San Francisco, USA;Department of Ophthalmology, University of California, San Francisco, USAView further author information
,
Jennifer Rose-NussbaumerFrancis I. Proctor Foundation, University of California, San Francisco, USA;Department of Ophthalmology, University of California, San Francisco, USAView further author information
&
Thomas M. LietmanFrancis I. Proctor Foundation, University of California, San Francisco, USA;Department of Epidemiology and Biostatistics, University of California, San Francisco, USA;Department of Ophthalmology, University of California, San Francisco, USAView further author information
 show all
Pages 315-322 | Received 23 Oct 2017, Accepted 16 Apr 2018, Published online: 02 May 2018

References

  • Oldenburg CE, Seage GR, Tanser F, et al. Antiretroviral therapy and mortality in rural South Africa: a comparison of causal modeling approaches. Am J Epidemiol. 2018; Forthcoming. doi:10.1093/aje/kwy065.
  • Oldenburg CE, Moscoe E, Barnighausen T. Regression discontinuity for causal effect estimation in epidemiology. Curr Epidemiol Rep. 2016;3(3):1–9. doi:10.1007/s40471-016-0080-x.
  • Bor J, Moscoe E, Mutevedzi P, Newell M-L, Barnighausen T. Regression discontinuity designs in epidemiology. Epidemiology. 2014;25(5):729–737. doi:10.1097/EDE.0000000000000138.
  • Moscoe E, Bor J, Barnighausen T. Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice. J Clin Epidemiol. 2015;68(2):132–143. doi:10.1016/j.jclinepi.2014.06.021.
  • Vandenbroucke JP, Le Cessie S. Regression discontinuity design: let’s give it a try to evaluate medical and public health interventions. Epidemiology. 2014;25(5):738–741. doi:10.1097/EDE.0000000000000145.
  • Shoag J, Halpern J, Eisner B, et al. Efficacy of prostate-specific antigen screening: use of the regression discontinuity in the PLCO cancer screening trial. JAMA Oncol. 2015;1(7):984–986. doi:10.1001/jamaoncol.2015.2993.
  • Bor J, Fox MP, Venkataramani A, Tanser F, Pillay D, Bärnighausen T. Treatment Eligibility and Retention in Clinical HIV Care: Regression-Discontinuity Evidence from South Africa. PLoS Med. 2017;14(11):e1002463.
  • Labrecque JA, Kaufman JS. Commentary. Epidemiology. 2016;27(4):500–502. doi:10.1097/EDE.0000000000000485.
  • Bor J, Moscoe E, Barnighausen T. Three approaches to causal inference in regression discontinuity designs. Epidemiology. 2015;26(2):e28. doi:10.1097/EDE.0000000000000231.
  • Prajna NV, Krishnan T, Mascarenhas J, et al. The Mycotic Ulcer Treatment Trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013;131(4):422. doi:10.1001/jamaophthalmol.2013.1497.
  • Prajna NV, Krishnan T, Rajaraman R, et al. Mycotic Ulcer Treatment Trial II Group. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial. JAMA Ophthalmol. 2016;134(12):1365–1372.
  • Oldenburg CE, Bor J, Harling G, et al. Impact of early antiretroviral therapy eligibility on HIV acquisition. Aids. 2018;32:635–643. doi:10.1097/QAD.0000000000001737.
  • Smith LM, Strumpf EC, Kaufman JS, Lofters A, Schwandt M, Levesque LE. The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts. Pediatrics. 2015;135(5):e1131–e1140. doi:10.1542/peds.2014-2961.
  • Barnighausen T, Oldenburg C, Tugwell P, et al. Quasi-experimental study designs series – paper 7: assessing the assumptions. J Clin Epidemiol. 2017 March;1–29. doi:10.1016/j.jclinepi.2017.02.017.
  • Smith LM, Kaufman JS, Strumpf EC, Levesque LE. Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study. Cmaj. 2015;187(2):E74–E81. doi:10.1503/cmaj.
  • Hernan MA, Taubman SL. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes Relat Metab Disord. 2008;32:S8–S14. doi:10.1038/ijo.2008.82.
  • Lalitha P, Sun CQ, Prajna NV, et al. In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial. Am J Ophthalmol. 2014;157(2):318–326. doi:10.1016/j.ajo.2013.10.004.
  • Kaptchuk TJ, Miller FG. Placebo effects in medicine. N Engl J Med. 2015;373(1):8–9. doi:10.1056/NEJMp1506446.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.